Trial intelligence / Profile preview

GERD treatment in mustard gas-exposed patients with chronic cough

IRCT2012072510398N1Phase 3Completed

Sponsor
Chemical Injuries Research Center
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Chemical Injuries Research Center. Started Jan 2008; status: completed.

02

Drugs

omeprazole
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on IRCT2012072510398N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2012072510398N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call